Merchant Anand, Smielewska Magda, Patel Nimit, Akunowicz Jennifer D, Saria Elizabeth A, Delaney John D, Leach Robin J, Seton Margaret, Hansen Marc F
Center for Molecular Medicine, University of Connecticut Health Center, Farmington, Connecticut 06030, USA.
J Bone Miner Res. 2009 Mar;24(3):484-94. doi: 10.1359/jbmr.081105.
Paget's disease of bone (PDB) is a focal disorder of bone remodeling that leads to overgrowth of affected bone, with rare progression to osteosarcoma. Extensive studies of familial PDB showed that a majority of cases harbor germline mutations in the Sequestosome1 gene (SQSTM1). In contrast, little is known about the mutational status of SQSTM1 in sporadic PDB. We hypothesized that somatic SQSTM1 mutations might occur in the affected tissues of sporadic PDB and pagetic osteosarcoma. We used laser capture microdissection to capture homogeneous populations of cells from the affected bone or tumor of patients with sporadic PDB or pagetic osteosarcoma, respectively. DNA from these samples and appropriate controls was used for sequence analysis and allelic discrimination analysis. Two of five patients with sporadic PDB had SQSTM1(C1215T) mutations detected in their affected bone but not in their blood samples, indicating a somatic origin of the mutations. Samples from three of five sporadic pagetic osteosarcoma patients had the SQSTM1(C1215T) mutation, whereas the normal adjacent tissue from two of these tumors clearly lacked the mutation, again indicating an occurrence of somatic events. No SQSTM1 mutations were found in primary adolescent osteosarcomas. The discovery of somatic SQSTM1 mutations in sporadic PDB and pagetic osteosarcoma shows a role for SQSTM1 in both sporadic and inherited PDB. The discovery of somatically acquired mutations in both the diseased bone and tumor samples suggests a paradigm shift in our understanding of this disease.
骨佩吉特病(PDB)是一种局限性骨重塑紊乱疾病,可导致受累骨骼过度生长,极少进展为骨肉瘤。对家族性PDB的广泛研究表明,大多数病例的Sequestosome1基因(SQSTM1)存在种系突变。相比之下,散发性PDB中SQSTM1的突变状态知之甚少。我们推测,体细胞SQSTM1突变可能发生在散发性PDB和佩吉特骨肉瘤的受累组织中。我们使用激光捕获显微切割技术,分别从散发性PDB患者或佩吉特骨肉瘤患者的受累骨骼或肿瘤中捕获同质细胞群体。这些样本和适当对照的DNA用于序列分析和等位基因鉴别分析。五名散发性PDB患者中有两名在其受累骨骼中检测到SQSTM1(C1215T)突变,但在其血液样本中未检测到,这表明这些突变起源于体细胞。五名散发性佩吉特骨肉瘤患者中有三名的样本存在SQSTM1(C1215T)突变,而其中两个肿瘤的相邻正常组织明显没有该突变,这再次表明存在体细胞事件。在原发性青少年骨肉瘤中未发现SQSTM1突变。散发性PDB和佩吉特骨肉瘤中体细胞SQSTM1突变的发现表明,SQSTM1在散发性和遗传性PDB中均起作用。患病骨骼和肿瘤样本中体细胞获得性突变的发现表明,我们对这种疾病的理解发生了范式转变。